August 2011

Gerolymatos International and Ferrer join forces to launch Sinomarin® in various markets in North Africa and the Middle East

Gerolymatos International, a leading Greek multinational, OTC pharmaceutical and cosmetics company, has granted Ferrer, one of the top Spanish R&D-based pharmaceutical companies, the exclusive distribution rights to market Sinomarin®, a hypertonic sea water family of products, in Algeria, Morocco, Iraq, Pakistan and Malta. This collaboration reinforces Gerolymatos International’s global presence with Sinomarin® and complements Ferrer’s portfolio, worldwide distribution network and international profile. This strategic alliance is expected to generate a significant turnover for both companies in the next few years.

Sinomarin® is a hypertonic seawater solution used for the decongestion and cleansing of nasal cavities that was initially developed and marketed in France, but soon expanded to 36 countries globally, including USA, Canada, Central and South America, Europe, Asia and Africa. The seawater is derived from a fully-owned seawater source at Cancale, near Saint Malo, France and is manufactured at Gerolymatos International's facilities located in Athens, Greece. Sinomarin® is a CE-Mark-bearing medical device and holds a patent in a number of key territories. It is a cohesive family of hypertonic products comprising an adult spray, a children’s spray, a mini spray and monodose vials for infants and toddlers. Additional products are currently being developed to further expand the existing Sinomarin® brand within the next few months.

Gerolymatos International S.A. has been associated with the health care and beauty industry since 1923 when the founder opened a pharmacy in the centre of Athens. The company swiftly grew in size and began its export activities in the 1970s and since then, it has continuously expanded its international network to over 50 countries through partnerships and affiliates across the five continents. Today, Gerolymatos International is a major global player in the field of natural seawater-based products such as Sinomarin® and a well established player in OTC pharmaceutical products.

Ferrer was founded in 1959 and is a privately-held Spanish pharmaceutical company, fully integrated from R&D to distribution. It is present in more than 90 countries and has 23 international affiliates. Ferrer is active in the pharmaceutical, health, fine chemicals and food sectors, key areas for contributing to people’s health and quality of life. Since the beginning, Ferrer has been committed to the research and development of innovative medicinal products in its six R&D centres and to a solid industrial structure, with thirteen manufacturing centers. In recent years, it has concentrated on diversifying across the whole healthcare spectrum and setting-up and consolidating strategic alliances. The result has been a significant globalization of its activities, backed up by an efficient management of regulatory affairs, with more than 1300 active registrations worldwide.



Disclaimer | Copyright ©  Gerolymatos International SA